News

heart valve repair hybrid or cath lab reprise II boston scientific lotus tct

In a clinical trial of the Boston Scientific Lotus valve, a second-generation ...

heart valve, direct flow, transcatheter aortic, TCT

Direct Flow Medical Inc. announced six-month data from the fully enrolled DISCOVER CE mark trial of the Direct Flow Medical Transcatheter Aortic Valve System.

heart valve repair clinical trial study abbott mitraclip TCT

Abbott announced clinically meaningful changes to quality of life, a reduction in rehospitalization for heart failure and functional improvements for patients treated with the company's first-in-...

heart valve repair hybrid or cath lab structural heart tct medtronic corevalve

In a clinical trial, a self-expanding transcatheter aortic valve met the key performance objective of reducing...

heart valve repair hybrid or cath lab

Boston Scientific Corp. has received CE mark for its Lotus Valve System, a transcatheter aortic valve replacement (TAVR) technology. This key approval offers an effective new...

trial study hybrid or heart valve repiar tct 2013 st. jude portico

St. Jude Medical Inc. announced positive results for the 23 and 25mm Portico Transcatheter Aortic Heart Valves in the Portico Transfemoral CE mark trial (Portico TF CE Trial)....

medtronic corevalve cath lab hybrid or heart valve repair study TCT 2013

The CoreValve U.S. pivotal trial showed very positive results for the Medtronic CoreValve system, comparable or better than data from the Sapien Partner Trial.

heart valve repair valve-in-valve melody transcatheter pulmonary houston

A new valve recently approved by the U.S. Food and Drug Administration (FDA) now gives heart patients a new way to manage their disease without having to undergo open ...

heart valve repair clinical trial study colibri tavi TCT

Colibri Heart Valve LLC, a medical device company, announced that patient enrollment has concluded in...

MitraClip, Abbott, transcatheter mitral valve repair, FDA approval

The U.S. Food and Drug Administration (FDA) has granted market clearance for the MitraClip, the first minimally invasive transcatheter device to repair mitral regurgitation (MR). The device is...

heart valve repair clinical trial study valtech cardio cardioband annuloplasty

Valtech Cardio Ltd., a medical device company that develops solutions for mitral valve repair and...

heart valve repair clinical trial study transcatheter aortic valve trinity

Transcatheter Technologies GmbH, a medical device company, announced the successful first-in-human implantation of its transapical Trinity aortic ...

heart valve repair medtronic corevalve evolut recapturable

Medtronic Inc. announced the first implants in the CoreValve Evolut R clinical study, which will evaluate the safety and effectiveness of the CoreValve Evolut R recapturable system. This recapture...

cardiovascular ultrasound structural heart valve repair hollywood presbyterian

A mother and her 25-week-old fetus are doing well after a team of physicians performed a successful in utero...

Sapien, TAVR, hybrid OR

As a cutting-edge technique, many hospitals around the country are investigating the development of their own TAVR programs. Starting a TAVR program requires a collaborative commitment to care and...

The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2013...

CardioLogical Solutions announced that it has been issued two additional patents for its family of aortic embolic protection devices designed to prevent stroke and other ischemic complications....

JenaValve, TAVI system, heart valve repair, CE Mark, JenaValve CE Mark

JenaValve Technology, Inc. announced that it has raised $62.5 million in a Series C venture round.

aortic valve, Edwards Lifesciences, SAPIEN, SAPIEN aortic valve

Edwards announced a new post-hoc data analysis from The PARTNER Trial demonstrated that diabetic patients with aortic stenosis in need of heart valve replacement, but at high surgical risk,...

Lotus Valve System, heart valves, Boston Scientific Corporation

Boston Scientific reported favorable six-month results from the first 60 patients enrolled in the REPRISE II clinical trial evaluating the safety and performance of the Lotus Valve System in...